220 related articles for article (PubMed ID: 26589875)
1. Additive impact of pre-liver transplant metabolic factors on survival post-liver transplant.
Adams LA; Arauz O; Angus PW; Sinclair M; MacDonald GA; Chelvaratnam U; Wigg AJ; Yeap S; Shackel N; Lin L; Raftopoulos S; McCaughan GW; Jeffrey GP;
J Gastroenterol Hepatol; 2016 May; 31(5):1016-24. PubMed ID: 26589875
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
[TBL] [Abstract][Full Text] [Related]
4. Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma.
de Ataide EC; Garcia M; Mattosinho TJ; Almeida JR; Escanhoela CA; Boin IF
Transplant Proc; 2012 Oct; 44(8):2438-40. PubMed ID: 23026614
[TBL] [Abstract][Full Text] [Related]
5. Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation.
Siegel AB; Lim EA; Wang S; Brubaker W; Rodriguez RD; Goyal A; Jacobson JS; Hershman DL; Verna EC; Zaretsky J; Halazun K; Dove L; Brown RS; Neugut AI; Kato T; Remotti H; Coppleson YJ; Emond JC
Transplantation; 2012 Sep; 94(5):539-43. PubMed ID: 22864187
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
Taniguchi M
Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
[TBL] [Abstract][Full Text] [Related]
7. New-onset diabetes after liver transplantation and its impact on complications and patient survival.
Lv C; Zhang Y; Chen X; Huang X; Xue M; Sun Q; Wang T; Liang J; He S; Gao J; Zhou J; Yu M; Fan J; Gao X
J Diabetes; 2015 Nov; 7(6):881-90. PubMed ID: 25676209
[TBL] [Abstract][Full Text] [Related]
8. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.
Bambha KM; Dodge JL; Gralla J; Sprague D; Biggins SW
Liver Transpl; 2015 Oct; 21(10):1286-94. PubMed ID: 26097202
[TBL] [Abstract][Full Text] [Related]
9. Rapid fibrosis and significant histologic recurrence of hepatitis C after liver transplant is associated with higher tumor recurrence rates in hepatocellular carcinomas associated with hepatitis C virus-related liver disease: a single center retrospective analysis.
Vasavada BB; Chan CL
Exp Clin Transplant; 2015 Feb; 13(1):46-50. PubMed ID: 25654412
[TBL] [Abstract][Full Text] [Related]
10. Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant.
Montenovo M; Rahnemai-Azar A; Reyes J; Perkins J
Exp Clin Transplant; 2018 Apr; 16(2):166-171. PubMed ID: 28621635
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States.
Berry K; Ioannou GN
Gastroenterology; 2015 Sep; 149(3):669-80; quiz e15-6. PubMed ID: 26021233
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation.
Zhang W; Kim R; Quintini C; Hashimoto K; Fujiki M; Diago T; Eghtesad B; Miller C; Fung J; Tan A; Menon KV; Aucejo F
Liver Transpl; 2015 Jan; 21(1):101-11. PubMed ID: 25283528
[TBL] [Abstract][Full Text] [Related]
13. Worse Long-term Patient Survival and Higher Cancer Rates in Liver Transplant Recipients With a History of Smoking.
Mangus RS; Fridell JA; Kubal CA; Loeffler AL; Krause AA; Bell JA; Tiwari S; Tector J
Transplantation; 2015 Sep; 99(9):1862-8. PubMed ID: 26308417
[TBL] [Abstract][Full Text] [Related]
14. Effect of body mass index on survival after curative therapy for non-B non-C hepatocellular carcinoma.
Nishikawa H; Osaki Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Arimoto A; Kita R; Kimura T
J Gastrointestin Liver Dis; 2013 Jun; 22(2):173-81. PubMed ID: 23799216
[TBL] [Abstract][Full Text] [Related]
15. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
16. Post-liver transplant survival in hepatitis C patients is improving over time.
O'Leary JG; Randall H; Onaca N; Jennings L; Klintmalm GB; Davis GL
Liver Transpl; 2009 Apr; 15(4):360-8. PubMed ID: 19326409
[TBL] [Abstract][Full Text] [Related]
17. Diabetes With or Without Hypertension Does Not Affect Graft Survival and All-cause Mortality After Liver Transplant: A Propensity Score Matching Analysis.
Kwon HM; Moon YJ; Jung KW; Sang BH; Hwang GS
Transplant Proc; 2018 May; 50(4):1123-1128. PubMed ID: 29731078
[TBL] [Abstract][Full Text] [Related]
18. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
Na GH; Kim EY; Hong TH; You YK; Kim DG
HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857
[TBL] [Abstract][Full Text] [Related]
19. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
20. Analysis of adult 20-year survivors after liver transplantation.
Dopazo C; Bilbao I; Castells LL; Sapisochin G; Moreiras C; Campos-Varela I; Echeverri J; Caralt M; Lázaro JL; Charco R
Hepatol Int; 2015 Jul; 9(3):461-70. PubMed ID: 25788182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
